Metoprolol Succinate Extended-Release Tablets 25 mg
Ascend Laboratories is recalling 25 mg Metoprolol Succinate Extended-Release Tablets due to failed dissolution testing.
Contact your healthcare provider or pharmacist to discuss alternative treatment options. Do not stop taking this medication without consulting your doctor.
Why it was recalled
Ascend Laboratories is recalling Metoprolol Succinate Extended-Release Tablets, 25 mg, due to failed dissolution testing. This medication is used to treat high blood pressure and chest pain.
Is mine affected?
Check the NDC or UPC and strength printed on the package. Yours is affected if it matches one below.
Ascend Laboratories, LLC, Metoprolol Succinate Extended-Release Tablets, USP
- Lot code
- 25140859
- Strength
- 25 mg
- UPC
- 25140859
Where it was sold
Distributed nationwide.
Timeline
- Firm initiated recall
- Publicly announced
- Listed on Recall Canary
- Summary updated
Official source
Other recent recalls from Ascend Laboratories, LLC
Editorial summary by Recall Canary · summary updated 2026-05-21 · primary source: U.S. Food and Drug Administration · severity reflects the agency's published classification